News
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director.
.jpeg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
%2520(1).jpeg)
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
.jpeg)
Product Clinic #1: Turning boring technology into exciting products
Don't be put off by the blunt use of the word "boring" to describe our technology. It's one of our guiding principles allowing us to make rapid progress while maintaining high quality standards. Read more here.
%2520(1).png)
James Lind and the Mafia
The story of how James Lind's trial for scurvy led to the formation of the mafia.
%2520(2).jpeg)
What actually improves diversity in clinical research?
We’ve all seen the evidence of ethnic minority underrepresentation but what is actually going to have an impact in the future? Read Lindus Health’s action plan here
Stagnation, Drugs and Eroom's law
Why does the cost of clinical trials continue to increase? Meri Beckwith, Lindus Health co-founder discusses why stagnation has prevailed and how technology is the answer
.jpeg)
Why I joined Lindus Health? Luke Twelves, Medical Lead
To help make trials more accessible to patients and clinicians. To help bring novel and innovative treatments to the frontline of care faster. To stretch myself and work as part of a really exciting team.
%2520(1).jpeg)
Vaccine Trials and Tribulations
Read co-founder Meri’s experience of a Covid-19 vaccine trial that left him frustrated (but vaccinated), and led to the creation of Lindus Health.
Cure Scurvy with this one weird trick…! Doctors hate him
In 1747 James Lind conducted the first clinical trial, proving that oranges and lemons were a cure for scurvy. Given that we’re named after him we felt it was about time we wrote a post about the history of scurvy, Lind, and the first ever clinical trial! We believe that in 100 years current health outcomes will seem just as ridiculous and intolerable as 50% of sailors dying of scurvy seems now, and that’s why we’re named Lindus Health.